WALTHAM, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:
- 13th Annual ROTH Technology Conference, New York City, November 19th – 20th, 2024
- Canaccord Genuity’s 2024 CG MedTech, Diagnostics and Digital Health & Services Forum, New York City, November 21st, 2024
Conference Details:
| 13th Annual ROTH Technology Conference | |
| Date: | Tuesday, November 19th – Wednesday 20th |
| Format: | 1x1 Meetings |
| Location: | The Hard Rock Hotel, New York City |
| Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum | |
| Date: | Thursday, November 21st |
| Format: | 1x1 Meetings |
| Location: | The Westin NY Grand Central, New York City |
To request a meeting or for more details about the conferences please reach out to your institutional contact or email.
About OptimizeRx
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 2 million U.S. healthcare providers and millions of their patients through an intelligent technology platform embedded within a proprietary digital point-of-care network, as well as mass digital communication channels, OptimizeRx helps life sciences organizations engage and support their customers.
For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com.
OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
adsilva@optimizerx.com
Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com
